Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

American Heart Association Meeting In Brief

This article was originally published in The Gray Sheet

Executive Summary

Evidence-Based HF treatment: Eligible heart failure patients in the United States are underutilizing professional guideline-recommended device and drug treatments, according to data from the Medtronic-sponsored, 40,000-patient IMPROVE HF registry presented at the American Heart Association Scientific Sessions in Orlando Nov. 7. According to the registry data, only about 39% of eligible patients are receiving cardiac resynchronization therapy and about 51% of indicated patients receive an implantable defibrillator. The registry also found that 36% of eligible patients are taking aldosterone antagonist drugs to manage congestive heart failure and 69% of eligible patients receive anticoagulants to mitigate the risk of atrial fibrillation. About 61% of patients receive heart failure education. Previous data from IMPROVE HF showed that, overall, fewer than 30% of patients were getting all the therapies they were eligible for under the guidelines, with women and older patients the most likely to be undertreated (1"The Gray Sheet" Sept. 25, 2006, p. 5)
Advertisement
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT025459

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel